CME Group (NASDAQ: CME), the Chicago-headquartered financial derivatives exchange, has strengthened its management team with two new appointments.

Paul Woolman assumes the role of Global Head of Equity Index Products having joined CME Group as the Senior Director, Head of EMEA Equity Products and Alternative Investments in 2016. With over two decades of experience in equity derivatives, Woolman, prior to joining CME Group (NASDAQ: CME), served as the Delta One Equity Derivatives Trading Director at Bank of America Merrill Lynch for 11 years.

Giovanni Vicioso has taken up the position of Global Head of Cryptocurrency Products having joined CME Group as Senior Director of Equity Products in 2012. Previously, Vicioso served as the Vice President for RBC Capital Markets' Equity Derivatives Group on their OTC Equity Derivatives desk and has more than three decades of experience within the financial industry.

Both Vicioso and Woolman will report to Tim McCourt, who was recently added to the CME Group management team as the Global Head of Equity and FX Products, having previously led both cryptocurrency and equity index products' business lines.

Commenting on their appointments, McCourt said: "Our equity and cryptocurrency businesses have experienced tremendous growth in recent years, underpinned by strong customer adoption and continued innovation."

CME Group Growth

The appointments come amidst a period of record growth for the world's largest financial derivatives marketplace. Last month, CME Group’s FX futures and options hit an all-time high volume.

In addition, the ADV for listed forex products in contract terms surged in September by 50% YoY, Q3 futures and options ADV increased by over 46% compared to Q3 2021. Meanwhile, Bitcoin futures ADV of 11.7K contracts rose by over 66% against Q3 2021.

Just a few weeks ago, CME Group launched binary option-styled event contracts aimed at retail traders.

CME Group (NASDAQ: CME), the Chicago-headquartered financial derivatives exchange, has strengthened its management team with two new appointments.

Paul Woolman assumes the role of Global Head of Equity Index Products having joined CME Group as the Senior Director, Head of EMEA Equity Products and Alternative Investments in 2016. With over two decades of experience in equity derivatives, Woolman, prior to joining CME Group (NASDAQ: CME), served as the Delta One Equity Derivatives Trading Director at Bank of America Merrill Lynch for 11 years.

Giovanni Vicioso has taken up the position of Global Head of Cryptocurrency Products having joined CME Group as Senior Director of Equity Products in 2012. Previously, Vicioso served as the Vice President for RBC Capital Markets' Equity Derivatives Group on their OTC Equity Derivatives desk and has more than three decades of experience within the financial industry.

Both Vicioso and Woolman will report to Tim McCourt, who was recently added to the CME Group management team as the Global Head of Equity and FX Products, having previously led both cryptocurrency and equity index products' business lines.

Commenting on their appointments, McCourt said: "Our equity and cryptocurrency businesses have experienced tremendous growth in recent years, underpinned by strong customer adoption and continued innovation."

CME Group Growth

The appointments come amidst a period of record growth for the world's largest financial derivatives marketplace. Last month, CME Group’s FX futures and options hit an all-time high volume.

In addition, the ADV for listed forex products in contract terms surged in September by 50% YoY, Q3 futures and options ADV increased by over 46% compared to Q3 2021. Meanwhile, Bitcoin futures ADV of 11.7K contracts rose by over 66% against Q3 2021.

Just a few weeks ago, CME Group launched binary option-styled event contracts aimed at retail traders.